FILANA THERAPEUTICS, INC. (FLNA) › Operating Cash FlowFILANA THERAPEUTICS, INC. (FLNA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$14.69M2010: -$143.0K2011: -$260.0K2012: -$7.17M2016: -$12.23M2017: -$8.24M2018: -$4.77M2019: -$2.51M2020: -$5.38M2021: -$30.20M2022: -$77.51M2023: -$82.03M2024: -$116.93M2025: -$32.25M-$32.25M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$32.25M+72.4%2024-$116.93M-42.6%2023-$82.03M-5.8%2022-$77.51M-156.7%2021-$30.20M-461.1%2020-$5.38M-114.1%2019-$2.51M+47.3%2018-$4.77M+42.1%2017-$8.24M+32.7%2016-$12.23M—2012-$7.17M-2658.1%2011-$260.0K-81.8%2010-$143.0K+99.0%2009-$14.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share